Accordingly, the Drug Administration recently received a report from the Hanoi Center for Drug, Cosmetic and Food Testing that the product sample had information on the label: Theophylline Extenderdrelease tablets 200mg (theophyllin 200mg), batch number 21127, manufacturing date 26-2-2022, expiration date 26-2-2026; place of manufacture Pharmacy Laboratories Plus, without information about the circulation registration number, import license number, and import facility on the label.
In particular, the drug sample did not meet the quality requirements for the quantitative index of Theophylline, reaching only 6.3% of the content stated on the label. The sample was taken by the Hanoi Center for Drug, Cosmetic and Food Testing at An An Pharmacy at the above address.

Faced with the above signs, the Drug Administration of Vietnam requested the Hanoi Department of Health to strictly handle the violating facility according to regulations and urgently trace the origin of the batch of drug products that do not meet quality requirements.
At the same time, the units are required to notify drug trading and usage establishments and people not to buy, sell or use the above products; promptly report any suspicious signs of production and trading of counterfeit drugs or drugs of unknown origin to health agencies and relevant authorities.
Theophylline Extended is a bronchodilator that relaxes smooth muscles in the airways and improves lung ventilation, so it is commonly used to treat asthma and chronic obstructive pulmonary disease.
Source: https://www.sggp.org.vn/phat-hien-thuoc-tri-benh-hen-gia-duoc-ban-tai-nha-thuoc-o-ha-noi-post797328.html
Comment (0)